Additional file 1 of Biological and clinical impact of membrane EGFR expression in a subgroup of OC patients from the phase IV ovarian cancer MITO-16A/MANGO-OV2A trial

Additional file 1: Sup. Table 1. Patient population of the MITO16A/MaNGO-OV2 in the analysis. Sup. Table 2. Association of EGFR membrane expression classified as negative and positive EGFR staining. Sup. Table 3. Multivariate analysis of PFS and OS for patients stratified for negative and positive EGFR staning. Sup. Table 4. Gene sets analyzed by single-sample GSVA in the MITO16A dataset of gene expression. Sup. Table 5. List of genes included in the EGFR-related gene sets. Sup. Table 6. Upstream regulators, included in the EGFR-related gene sets, and therir target genes predicted by IPA. Sup. Table 7. List of genes included in the networks generated by IPA from EGFR-related gene sets.